Assessing in-session rumination and its effects on CBT for depression.

Autor: Kennedy JC; Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University School of Medicine, Atlanta, GA, United States; Department of Psychology, Emory University, Atlanta, GA, United States., Dunlop BW; Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Craighead LW; Department of Psychology, Emory University, Atlanta, GA, United States., Nemeroff CB; Department of Psychiatry and Behavioral Sciences, Dell School of Medicine, University of Texas, Austin, TX, United States., Mayberg HS; The Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Craighead WE; Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University School of Medicine, Atlanta, GA, United States; Department of Psychology, Emory University, Atlanta, GA, United States. Electronic address: ecraigh@emory.edu.
Jazyk: angličtina
Zdroj: Behaviour research and therapy [Behav Res Ther] 2022 Dec; Vol. 159, pp. 104209. Date of Electronic Publication: 2022 Oct 09.
DOI: 10.1016/j.brat.2022.104209
Abstrakt: The study evaluated if rumination of patients during therapy (i.e., in-session rumination) relates to whether or not they do less well in CBT treatment. We developed a reliably assessed in-session rumination observational measure and evaluated its relationship to depression over the course of CBT. Rated sessions came from 63 treatment-naïve patients with major depressive disorder who participated in CBT in the PReDICT study (Dunlop et al., 2017). In-session rumination was operationalized as repetitive, negative, and passive talking about depressive topics. Trained undergraduates rated the intensity and duration of in-session rumination occurring during 57 initial therapy sessions (i.e., session one) and 45 sessions in the middle of treatment (i.e., session eight). The observational ratings were sufficiently reliable (all ICCs > 0.69). Mixed model results indicated that greater intensity of in-session rumination during the initial treatment session predicted higher levels of subsequent clinician-rated depressive symptoms (p < .023). Regression results indicated that greater intensity and duration of in-session rumination at session 8 significantly predicted higher clinician-rated symptoms at end of treatment (p's < 0.02). In-session rumination intensity and duration were not, however, related to subsequent self-reported depressive symptoms. The results support efforts to identify which patients might benefit from rumination-specific interventions.
(Copyright © 2022 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: